學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
More than Optics: Olympus's Vision to Become a Leading Global MedTech Company
內容大綱
In August 2022, CEO Yasuo Takeuchi reflected on Olympus Corporation's recent transformation from being known as a Japanese consumer camera company to becoming a leading global medical technology (MedTech) company. Over the past dozen years, Takeuchi and prior leadership had recovered from a major scandal and reinvented Olympus's purpose, governance, portfolio, organization structure and operating model. When asked if he could have done any better, he laughed with a humble smile. "There's no 'perfect' in the world-but we are doing almost perfectly. I am not a very optimistic type of person. But we are certainly advancing [the transformation] in the right direction. I have to say, it is working very well.'" Despite being on course, the journey was ongoing. Strategically, the evolving medical technology landscape demanded new capabilities-notably building an integrated digital solutions ecosystem. Organizationally, Takeuchi was at the helm of a matrix organization in which product divisions did not necessarily have full authority for all their activities; corporate functions were learning how to establish their global roles; and regional companies still drove local sales. And personnel issues remained a concern. Senior executive positions were staffed with "two in a box"-one Japanese and one non-Japanese manager-while Japanese employees were adapting to a job-based rather than a seniority system and the widespread use of the English language in meetings. How should Olympus navigate these challenges to deliver on its aspiration to be a leading global MedTech player?